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Editors: Anton N. Sidawy and Bruce A. PerlerCauses of late mortality after endovascular and open surgical repair of
infrarenal abdominal aortic aneurysms
Philip P. Goodney, Dale Tavris, F. Lee Lucas, Thomas Gross, Elliott S. Fisher,
Samuel R.G. Finlayson
Introduction: Several reports suggest unexpectedly high rates of late
abdominal aortic aneurysm (AAA) rupture occur after endovascular AAA
repair (EVAR). However, a population-based study examining causes of late
death after EVAR vs open surgical repair has not been performed.
Methods: We performed a retrospective cohort study of patients undergoing
infrarenal AAA repair using information from the Medicare inpatient hospital
discharge records (MedPAR files), physician claim files (Part B files, 20%
sample), and Medicare Denominator Files for the years 2001 to 2004. Using
the Social Security Death Index, we identified all ‘‘late’’ deaths, defined
as deaths occurring >30 days and after hospital discharge. We used the
National Death Index to identify cause of death information; in particular,
those deaths that were likely caused by late rupture. We compared causes
of late death and survival between EVAR and open repair using Wilcoxon
log-rank and rank-sum tests.
Results: Between 2001 and 2004, 13,971 patients underwent AAA repair
(6119 EVAR, 7852 open repair). After a mean follow-up of 1.6 years in the
EVAR cohort and 1.9 years in the open cohort, mortality rates were similar
across repair type (15.4% EVAR, 15.9% open repair), with an adjusted odds
ratio for death after open repair of 0.98 (95% confidence interval, 0.90-
1.07). Of the 2194 documented deaths, 523 occurred before discharge or
30 days, and 1671 occurred >30 days and after hospital discharge. Cause
of death information for the 1671 late deaths was available from the
National Death Index for 1515 (91%). The 15 most common codes for causes
of late death were dominated by cardiac disease (atherosclerotic heart
disease, acute myocardial infarction) and pulmonary disease (lung cancer,
respiratory failure). Causes of late death with specific mention of aneurysm
were identified in 37 patients (2.4% of all deaths), but this event was not
more common in EVAR or open repair (15 [0.3%] in the EVAR group, 22
[0.3%], in the open repair group; P = .71).
Conclusions: Late deaths from aneurysm rupture after EVAR or open repair
appear to be relatively infrequent and similarly distributed across procedure
type. Our results emphasize that the effectiveness of EVAR is comparable to
open AAA repair in preventing aneurysm-related death.Outcome of elective endovascular abdominal aortic aneurysm repair in
octogenarians and nonagenarians
Stuart B. Prenner, Irene C. Turnbull, Rajesh Malik, Alexander Salloum, Sharif
H. Ellozy, Angeliki G. Vouyouka, Michael L. Marin, Peter L. Faries
Objective: Compared to open repair of abdominal aortic aneurysms (AAA),
endovascular aneurysm repair (EVAR) is associated with decreased* Full articles available online at www.jvascsurg.org
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doi:10.1016/S1078-5884(10)00291-1perioperative morbidity and mortality. This study sought to examine the
outcomes of EVAR in patients 80 years of age.
Methods: This was a retrospective review from a prospectively maintained
computerized database. A total of 322 patients aged 80 underwent elec-
tive EVAR from January 1997 to November 2007. Mean age was 84 years 
3.4 years (range, 80-95 years), and 78.5% were male. Mean aneurysm size
was 62 mm  12 mm (range, 39-110 mm).
Results: Mean procedural blood loss was 350 mL (range, 50-2700 mL), and
13.9% required intraoperative transfusion. Mean length of postoperative stay
was 2.46 days (median, 1 day; range, 1-42 days), with 54.3% of patients dis-
charged on the first postoperative day. There were 25 (7.8%) perioperative
major adverse events. The most common were categorized as device-
related (6), cardiac (4), gastrointestinal (4), and bleeding/hematoma (3).
The perioperative 30-day mortality rate was 3.1% (10 of 322). Mean
follow-up was 25.7 months (range, 1-110 months). Overall, 47 patients
(14.6%) required secondary intervention, 7 patients (2.2%) underwent
conversion to open repair, and 4 patients (1.2%) died from AAA rupture. En-
doleaks occurred in 95 patients (29.4%), with 20 type I, 48 type II, and 27 of
indeterminate type; of these, 10 patients with type I endoleaks underwent
secondary intervention. Freedom from all-cause mortality at 1 year was
84.3% and at 5 years was 27.4%. Freedom from aneurysm-related mortality
at 5 years was 92.9%.
Conclusion: EVAR in octogenarians is associated with high procedural
success and low perioperative morbidity and mortality. The midterm results
of this study support the use of EVAR in this patient population. Further
studies are needed to predict short-term and long-term mortality risk, and
treatment for other causes of death.A comparative analysis of the outcomes of aortic cuffs and converters for
endovascular graft migration
Bradley G. Thomas, Luis A. Sanchez, Patrick J. Geraghty, Brian G. Rubin,
Samuel R. Money, Gregorio A. Sicard
Objective: Proximal attachment failure, often leading to graft migration, is
a severe complication of endovascular aneurysm repair (EVAR). Aortic cuffs
have been used to treat proximal attachment failure with mixed results. The
Zenith Renu AAA Ancillary Graft (Cook Inc, Bloomington, Ind) is available in
two configurations: converter and main body extension. Both provide prox-
imal extension with active fixation for the treatment of pre-existing endo-
vascular grafts with failed or failing proximal fixation or seal in patients
who are not surgical candidates. We prospectively compared the outcomes
of patient treatment with these two device configurations.
Methods: From September 2005 to May 2008, a prospective, nonrando-
mized, postmarket registry was conducted to collect data from 151 patients
treated at 95 institutions for proximal aortic endovascular graft failure using
the Renu graft. Treatment indications included inadequate proximal fixation
or seal, for example, migration, and type I and III endoleak. A total of 136
patients (90%) had migration, 111 (74%) had endoleak, and 94 (62%) had en-
doleaks and graft migration. AneuRx grafts were present in 126 patients
(83%), of which 89 (59%) were treated with a converter and 62 (41%) with
800 Abstractsa main body extension. Outcomes using converters vs main body extensions
for endoleak rates, changes in aneurysm size, and ruptures were compared.
Results: Preprocedural demographics between the two groups did not differ
significantly. Procedural success rates were 98% for the converter group and
100% for the main body extension group. At a mean follow-up of 12.8  7.5
months, no type III endoleaks (0%)were identified in the converter group,
and five (8%) were identified in the main body extension group. There were
no aneurysm ruptures in patients treated with converters (0%) and three
ruptures (5%) in patients treated with main body extensions. Each patient
with aneurysm rupture had been treated with a Renu main body extension,
developed a type III endoleak, and underwent surgical conversion. Two of
the three patients died postoperatively.
Conclusions: Proximal attachment failure and graft migration are poten-
tially lethal complications of EVAR. Proximal graft extension using an aortic
cuff is the easiest technique for salvaging an endovascular graft. Unfortu-
nately, it has a predictable failure mode (development of a type III endoleak
due to component separation) and is associated with a significantly higher
failure rate than with the use of a converter. EVAR salvage with a converter
and a femorofemoral bypass is a more complex but superior option for endo-
vascular graft salvage.Ultrasound-determined diameter measurements are more accurate than
axial computed tomography after endovascular aortic aneurysm repair
Sukgu M. Han, Kaushel Patel, Vincent L. Rowe, Susana Perese, Aaron Bond,
Fred A. Weaver
Objective: This study evaluated the correlation of ultrasound (US)-derived
aortic aneurysm diameter measurements with centerline, three-dimensional
(3-D) reconstruction computed tomography (CT) measurements after endo-
vascular aortic aneurysm repair (EVAR).
Methods: Concurrent CT and US examinations from 82 patients undergoing
post-EVAR surveillance were reviewed. The aortic aneurysm diameter was
defined as the major axis on the centerline images of 3-D CT reconstruction.
This was compared with US-derived minor and major axis measurements, as
well as with the minor axis measurement on the conventional axial CT
images. Correlation was evaluated with linear regression analyses. Agree-
ment between different imaging modalities and measurements was assessed
with Bland-Altman plots.
Results: The correlation coefficients from linear regression analyses were
0.92 between CT centerline major and US minor measurements, 0.94
between CT centerline major and US major measurements, and 0.93
between CT minor and centerline major measurements. Bland-Altman plots
showed a mean difference of 0.11 mm between US major and CT centerline
measurements compared with 5.38 mm between US minor and CT centerline
measurements, and 4.25 mm between axial CT minor and centerline
measurements. This suggested that, compared with axial CT and US minor
axis measurements, US major axis measurements were in better agreement
with CT centerline measurements. Variability between major and minor US
and CT centerline diameter measurements was high (standard deviation of
difference, 4.27-4.84 mm). However, high variability was also observed
between axial CT measurements and centerline CT measurements (standard
deviation of difference, 4.36 mm).
Conclusions: The major axis aneurysm diameter measurement obtained by
US imaging for surveillance after EVAR correlates well and is in better agree-
ment with centerline 3-D CT reconstruction diameters than axial CT.Carotid artery stent fracture identification and clinical relevance
Gioacchino Coppi, Roberto Moratto, Jessica Veronesi, Emanuele Nicolosi,
Roberto Silingardi
Background: This study was conducted to identify the prevalence, risk
factors, and clinical relevance of carotid artery stent fracture.
Methods: Commercially available carotid stents were implanted in this
prospective, observational study that began in January 2004. Indications
included asymptomatic patients (stenosis >80%), symptomatic patients
(stenosis >60%), and ulcerated lesions (>50%). Stent integrity was assessed
with plain radiography at 12 months. Data were analyzed in April 2009 on
a series of 341 consecutive patients treated with carotid artery stenting with
at least 12 months follow-up.Results: Stent fracture prevalence was 3.4% at 12 months (95% confidence
interval, 1.7%-6.1%). The median clinical follow-up was 30 months (range,
12-64 months) for 323 eligible patients. Treatment included 23.6% of symp-
tomatic patients. According to univariate analysis, calcification type III
increased the odds of stent fracture by more than 4.5 times (odds ratio
[OR], 4.74; P = .006) and angulation >45 increased the odds of stent frac-
ture by 6.5 times (OR, 6.51; P = .008). Carotid stent cell type, stent length,
and stent over-sizing were not correlated with stent fracture incidence.
Stent fracture was not associated with stroke (0%), transient ischemic attack
(0%), or death (0%). Restenosis was significantly associated with stent frac-
ture (P < .001). Multivariate analysis evidenced that type III calcification
(OR, 3.90; P = .029) and angulation >45 (OR, 4.69; P = .026) were important
risk factors for carotid stent fracture.
Conclusions: Carotid stent fracture is a rare complication after CAS and is
associated with vessel angulation, calcification, and restenosis. In this
series, fracture identification was independent of stroke, transient ischemic
attack, and mortality.Endovascular interventions for TASC II D femoropopliteal lesions
Donald T. Baril, Rabih A. Chaer, Robert Y. Rhee, Michel S. Makaroun, Luke K.
Marone
Background: Advances in endovascular techniques have provided new
options in the treatment of complex infrainguinal occlusive lesions. The
purpose of this study was to evaluate outcomes of endovascular interven-
tions on TransAtlantic InterSociety (TASC) II D femoropopliteal occlusive
disease.
Methods: All patients undergoing endovascular interventions for femoropo-
pliteal occlusive disease between July 2004 and July 2009 were reviewed.
Patient demographics, pre- and postprocedure ankle-brachial indices (ABI)
and anatomic factors were analyzed. Outcomes evaluated included primary
patency, assisted-patency, secondary patency, predictors of restenosis, and
wound healing.
Results: Five hundred eighty-five limbs were treated during the period re-
viewed. The study group included 79 TASC D limbs in 74 patients (mean
age 76.5  11.9 years, male sex: 53%). Fifty-six limbs (71%) underwent treat-
ment for critical limb ischemia, including 42 (53%) with tissue loss. Eleven
patients (15%) had previous failed bypasses. Preoperative ABIs were unob-
tainable for 23 patients, while the remaining 56 had a mean baseline ABI
of 0.54  0.28. There was one periprocedural mortality. Five patients
(6.3%) had periprocedural complications. Mean increase in ABI postproce-
dure was 0.49  0.35. Follow-up was available for 74 limbs at a mean of
10.7 months (range, 1-35). There were 18 mortalities (24.3%) during the
follow-up period. No patient required a major amputation during this
follow-up period. Twenty-one limbs (26.6%) experienced restenosis and nine
limbs (11.4%) experienced occlusion. Twenty-nine limbs underwent reinter-
vention during the follow-up time, including nine which underwent multiple
reinterventions. Primary, assisted-primary, and secondary patency rates at
12 and 24 months were 52.2%, 88.4%, 92.6% and 27.5%, 74.2%, and 88.9%,
respectively. Predictors of restenosis/occlusion included hypercholesterol-
emia, the presence of a popliteal artery stent, and patients who were
current or former smokers.
Conclusions: Endovascular interventions for TASC II D lesions can be safely
performed with excellent hemodynamic improvement and limb salvage
rates. Restenosis is not uncommon in this population, which mandates strict
follow-up. Further follow-up is necessary to determine the long-term effi-
cacy of these interventions.Retrospective evaluation of the need of a redo surgery at the groin for the
surgical treatment of varicose vein
Paul Pittaluga, Sylvain Chastanet, Timothe´e Locret, Olivier Rousset
Background: Surgical treatment for varicose recurrence (STVR) involves
removing all sources of reflux from the deep venous network to the superfi-
cial venous network. STVR is usually more complex and aggressive than first-
line treatment by stripping, particularly for redo surgery at the groin (RSG).
This retrospective study compared traditional STVR and a less aggressive
surgical approach focusing on treatment of the varicose reservoir and avoid-
ing RSG if possible.
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ping were compared: traditional STVR (T1) and STVR focusing on the varicose
reservoir (T2). We reviewed postoperative complications and studied the
hemodynamic and clinical results.
Results: During T1 and T2, we operated 473 legs in 288 patients (236
women, 52 men) to treat varicose recurrence after great saphenous vein
stripping. Mean age was 60.83 years (range, 28-88 years). We operated on
137 patients during T1 and 151 during T2. Patients had similar demographic
data, CEAP classification, and Venous Disability Score. Inguinal reflux
occurred in 73.9% of T1 patients and in 74.4% of T2 patients. We performed
RSG in 66.0% of T1 patients and in 2.2% of T2 patients (P < .05). We did not
use echo-guided sclerotherapy in addition to primary STVR. Tumescent local
anesthesia was used in 96.2% of STVR in T2 vs 4.0% in T1 (P < .05), and 95.3%
of T2 procedures were outpatient vs 13.7% of T1 (P < .05). Outcomes of limbs
presenting an inguinal reflux treated with RSG during T1 (group 1) and
without RSG during T2 (group 2) were compared. Postoperative complica-
tions occurred in 6.7% in group 1 vs 0.5% in group 2 (P < .05), with inguinal
complications predominating. The mean cost of the procedure per limb was
V1,195.88 in group 1 vs V863.08 in group 2 (P < .0001). After 3 years of
follow-up, Kaplan-Meier life-table analysis showed group 1 and 2 patients
had similar rates of freedom from inguinal reflux (90.8% vs 92.9% survival
rate) and from varicose repeat-recurrence (90.8% vs 91.9% survival rate).
Group 1 had better results for the Venous Disability Score (0.38 vs 0.58,
P = .02) and cosmetic improvement (94.2% vs 84.2%; P = .00032).
Conclusion: STVR focusing on the varicose reservoir and avoiding RSG led to
a minimally invasive procedure and a reduction in postoperative complica-
tions, with good medium-term clinical and hemodynamic results, particu-
larly for symptoms improvement and cosmetic appearance, with a lower
cost vs traditional STVR with RSG.National trends in venous disease
GeoffreyD.Barnes, SameerGafoor,ThomasWakefield,GilbertR.Upchurch Jr,
Peter Henke, James B. FroehlichBackground: The national burden of venous disease and use of ultrasound
(US) in the outpatient and emergency department (ED) settings has not been
well described. The objective of this study is to describe venous disease in
the outpatient and ED settings nationally as well as to characterize the
use of US for diagnosis of venous disease, including phlebitis.
Methods: Data from the 1997 to 2006 National Ambulatory Medical Care
Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey
(NHAMCS) were compiled, and complex sampling methods were used to
describe the number of outpatient and ED visits for adults given a diagnosis
of venous disease or phlebitis by ICD-9 coding. Logistic regression analysis
with calculated odds ratios are used to examined patient visit characteristics
and use of US.
Results: During the 10 years studied, an office or ED visit for venous disease
occurred over 46 million times, for an average of 4.6 million visits per year,
with this rate increasing from 4.03 million to 5.71 million per year (odds ratio
[OR] 1.01, confidence interval [CI] 1.00-1.01). The majority of these patients
were seen by specialists, such as surgeons or cardiologists, but a significant
number were also seen by primary care providers (PCP). There were 2
million office visits (PCP and specialists) on average per year with no signif-
icant increase. There were approximately 236,000 ED visits for deep vein
thrombosis (DVT) on average per year, which showed a small increase (OR
1.01, CI 1.00-1.01). Visits for DVT and phlebitis were as likely to be seen
by PCPs as ED physicians. Non-DVT venous disease is much more likely to
be seen by a surgeon (OR 4.88, CI 3.53-6.74) than a PCP. DVT is much less
likely to be diagnosed by a specialist (OR 0.27, CI 0.18-0.29) than a PCP.
Insurance status and geographic region were not associated with DVT or
non-DVT venous disease diagnosis.
Conclusions: Nationally, a significant and growing number of patients with
venous disease are being seen in the outpatient setting by PCPs and special-
ists. A significant number of patients with DVT are being seen in the outpa-
tient setting, but without a trend away from care in the ED over the 10-year
study period. Additionally, the majority of patients with DVT diagnosis do
not seem to be getting ultrasounds at the same visit. Many of these patients
are being seen by PCPs who may require additional training and infrastruc-
ture for appropriate patient care.
